Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...

J&J receives CHMP positive opinion for Akeega to treat patients with metastatic hormone-sensitive prostate cancer with BRCA1/2 mutations: Beerse, Belgium Monday, February 2, 2026, ...

When an intervention prevents a clean disaster, the way a rabies shot does, sanity shows up: it gets used, it stays cheap, ...

Canada's top official for defense procurement visited the Hanwha Ocean shipyard iin connection with Ottawa's ...

Junior research group leader Dr. Anne Fassl from the Department of Urology at Universitätsmedizin Frankfurt has been awarded a Young Investigator Award 2025 by the U.S.-based Prostate Cancer ...

A team of researchers have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks. This study, conducted by researchers from the Andalusian ...

PRESS RELEASEAB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE ...

The NHS diagnoses kidney cancer late in almost three quarters of cases. The condition is notoriously hard to detect, and the ...

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University ...

Today Bayer announced it has teamed up with former professional quarterback, Tony Romo, on ?Highlights REAL,' a campaign ...

Analyses of large health databases suggest common diabetes treatments may lower obesity-linked tumor risk; clinicians note unresolved rare safety issues.